These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. HLA-DQ distribution and risk assessment of celiac disease in a Spanish center. Martínez-Ojinaga E; Molina M; Polanco I; Urcelay E; Núñez C Rev Esp Enferm Dig; 2018 Jul; 110(7):421-426. PubMed ID: 29699404 [TBL] [Abstract][Full Text] [Related]
23. HLA-DQ7 haplotype among individuals with suspected celiac disease. Flores-Marin DL; Linden J; Frank E; Pena R; Silvester JA; Therrien A Dig Liver Dis; 2024 Aug; 56(8):1414-1416. PubMed ID: 38825411 [No Abstract] [Full Text] [Related]
24. Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. Segni M; Pani MA; Pasquino AM; Badenhoop K J Clin Endocrinol Metab; 2002 Aug; 87(8):3779-82. PubMed ID: 12161510 [TBL] [Abstract][Full Text] [Related]
25. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053 [TBL] [Abstract][Full Text] [Related]
26. Surprises from celiac disease. Fasano A Sci Am; 2009 Aug; 301(2):54-61. PubMed ID: 19634568 [No Abstract] [Full Text] [Related]
27. A new PCR-SSP method for HLA DR-DQ risk assessment for celiac disease. Lavant EH; Agardh DJ; Nilsson A; Carlson JA Clin Chim Acta; 2011 Apr; 412(9-10):782-4. PubMed ID: 21219892 [TBL] [Abstract][Full Text] [Related]
28. Celiac disease is a good disease--HLA association model [corrected]. González-Roiz C; López-Rodriguez MJ; F-Pereira L; Pedrera Zamorano JD J Pediatr Gastroenterol Nutr; 2004 Nov; 39(5):569-70. PubMed ID: 15572904 [No Abstract] [Full Text] [Related]
29. Pediatric screening of celiac disease and predisposing HLA-related alleles: The role of the DQ7.5 haplotype. Lionetti E; Catassi C; Catassi GN Dig Liver Dis; 2024 Sep; 56(9):1648. PubMed ID: 38918125 [No Abstract] [Full Text] [Related]
30. HLA and celiac disease in Argentina: involvement of the DQ subregion. Palavecino EA; Mota AH; Awad J; Derosa S; Herrera M; Chertkoff L; Satz L; Fainboim L Dis Markers; 1990; 8(1):5-10. PubMed ID: 2311351 [TBL] [Abstract][Full Text] [Related]
31. [A comparative study of HLA-DR phenotype in children with celiac disease from Aragon and in control population from the same region]. Ruiz del Prado MY; Olivares López JL; Lázaro Almarza A Med Clin (Barc); 2000 Jun; 115(1):36. PubMed ID: 10953836 [No Abstract] [Full Text] [Related]
32. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes. Bratanic N; Smigoc Schweiger D; Mendez A; Bratina N; Battelino T; Vidan-Jeras B Tissue Antigens; 2010 Sep; 76(3):208-15. PubMed ID: 20492597 [TBL] [Abstract][Full Text] [Related]
33. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Bilbao JR; Calvo B; Aransay AM; Martin-Pagola A; Perez de Nanclares G; Aly TA; Rica I; Vitoria JC; Gaztambide S; Noble J; Fain PR; Awdeh ZL; Alper CA; Castaño L Genes Immun; 2006 Oct; 7(7):550-4. PubMed ID: 16929349 [TBL] [Abstract][Full Text] [Related]
34. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Megiorni F; Mora B; Bonamico M; Barbato M; Montuori M; Viola F; Trabace S; Mazzilli MC Am J Gastroenterol; 2008 Apr; 103(4):997-1003. PubMed ID: 18177450 [TBL] [Abstract][Full Text] [Related]
35. HLA DR-DQ genotyping by capillary electrophoresis for risk assessment for celiac disease. Lavant EH; Carlson J Methods Mol Biol; 2013; 919():297-307. PubMed ID: 22976110 [TBL] [Abstract][Full Text] [Related]
36. PREVALENCE OF CELIAC DISEASE PREDISPOSING GENOTYPES, INCLUDING HLA-DQ2.2 VARIANT, IN BRAZILIAN CHILDREN. Selleski N; Almeida LM; Almeida FC; Pratesi CB; Nóbrega YKM; Gandolfi L Arq Gastroenterol; 2018; 55(1):82-85. PubMed ID: 29561984 [TBL] [Abstract][Full Text] [Related]
37. HLA-G and susceptibility to develop celiac disease. Catamo E; Zupin L; Segat L; Celsi F; Crovella S Hum Immunol; 2015 Jan; 76(1):36-41. PubMed ID: 25500250 [TBL] [Abstract][Full Text] [Related]
38. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response. Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396 [TBL] [Abstract][Full Text] [Related]
39. Celiac disease: sandwiched between innate and adaptive immune responses induced by gluten. Koning F J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E8-9. PubMed ID: 18354329 [No Abstract] [Full Text] [Related]
40. Genetic background of celiac disease and its clinical implications. Wolters VM; Wijmenga C Am J Gastroenterol; 2008 Jan; 103(1):190-5. PubMed ID: 18184122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]